Ian Cheeseman joined Texas Biomed in 2010 as a postdoctoral fellow in Tim Anderson’s lab. In 2014 he became one of the youngest recipients of a major NIH award when he received $1.8 million to pursue his “single cell genomics” approach to investigating malaria infections. He was recently invited to join the Pf3K consortium, an international effort to characterize genetic variation and the impact of natural selection in more than 3,000 directly sequenced malaria parasite genomes. The Cheeseman laboratory uses genomic and computational approaches to characterize the complexity of malaria infections, the evolution of drug resistance, and the rate and spectrum of adaptive mutations in the malaria parasite genome. Cheeseman received his PhD in parasite genetics and his MS degree in molecular biology of infectious diseases from the London School of Hygiene and Tropical Medicine.